Skip to main content
. 2022 Nov 23;10(5):2082–2096. doi: 10.1016/j.gendis.2022.10.021

Figure 3.

Fig. 3

LRP1B mutation-related DEGs and functional enrichment analysis. (A–J) Expression levels of f106 (A), SCN1B (B), DNASE1L3 (C), APTR (D), TCF19 (E), LOC101927021 (F), TMEM14A (G), TMEM97 (H), LOC730101 (I) and LIMD1 (J) in the LRP1B mutant and wild-type groups. (K–O) Molecular structure diagrams of serdemetan (K), alisertib (L), caffeic acid (M), pyrimethamine (N), and doxorubicin (O). (P) Gene ontology (GO) enrichment analysis. (Q) Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis.